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This Month in the Journal
Tumorigenesis occurs in multiple steps, of which cellular
hyperproliferation is only one early manifestation. Com-
pared with the early steps of tumor induction, the later
events—changes in adhesive interactions; loss of contact
inhibition; increased capacity to extravasate, to metas-
tasize, and to induce angiogenesis—have received rela-
tively little attention from geneticists. Here we feature
three articles on the genetics of cancer outcome. Narod
(p. 1) discusses the effects that inherited variation in
known tumor-suppressor genes and proto-oncogenes ex-
erts on cancer progression. Hartsough and Steeg (p. 6)
focus on nm23-H1, a highly conserved protein that spe-
cifically suppresses metastasis but not tumorigenesis. Fi-
nally, the progression of disease may depend crucially
on a patient’s idiosyncratic responses to cancer che-
motherapy, as Krynetski and Evans (p. 11) show. They
consider the drug-metabolizing enzyme thiopurine S-
methyltransferase and show that accurate diagnosis of
a genetic deficiency in this enzyme permits the clinician
to choose a dose that is effective but that avoids poten-
tially fatal toxicity.
In the “Book Reviews” section, Vieland and Hodge
(p. 283) recount the argument of biostatistician Richard
Royall in his recent book Statistical Evidence: A Like-
lihood Paradigm. They build from his general model a
view that they call “evidentialism,” which, they argue,
can eliminate some unresolvable disputes in statistical
genetics, notably the recent debate on significance levels
in genome scans.
Differences between Autosomal and X DNA, by
White et al. (p. 20)
The silencing of loci on one of the two female X chro-
mosomes correlates both with the formation of hetero-
chromatin in the silenced chromosome and with a shift
toward replication later in S phase. This process is in-
complete, sparing the pseudoautosomal region of the
chromosome as well as some scattered loci that some-
how escape X inactivation. When autosomal domains
translocate to the X, they become subject to a similar
epigenetic modification. The timing of DNA replication
in these domains is inconsistent between loci, raising the
possibility that efficient silencing depends on some prop-
erties of X-chromosome DNA sequences. White and co-
workers have isolated an Xq:4q derivative chromosome
in a somatic-cell hybrid and have used reverse transcrip-
tion–PCR to follow expression of translocated autoso-
mal genes in this cell clone. They report here that X
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inactivation could propagate x100 Mb into the se-
quence derived from 4q but that 6 of 20 genes and ex-
pressed sequence tags tested had escaped inactivation.
No simple rule based either on the location of these loci
in the translocated region or on the presence of CpG
islands in their promoters could account for this pattern
of expression.
mtDNA Stop-Codon Point Mutation, by Hanna et al.
(p. 29)
Hanna et al. present the first evidence for a nonsense
mutation in a mitochondrial protein gene. Other point
mutations in tRNA genes and in electron-trans-
port–chain protein genes have been associated with pro-
gressive muscle disorders such as mitochondrial enceph-
alomyopathy with lactic acidosis and strokelike episodes
(MELAS). Premature-termination codons in any of the
mitochondrial open reading frames had never been re-
ported, but the subject of this study is heteroplasmic for
a stop mutation that maps near a previously identified
missense mutation in the gene for a respiratory-complex
IV subunit. That missense mutation is known to confer
MELAS, and the phenotype of the novel mutation seems
to be similar, including both exercise-induced lactic ac-
idosis and adult-onset muscular weakness. The subject’s
skeletal muscle contains 150% mutant mtDNA, with
dramatically more wild-type DNA in cytochrome
oxidase (COX)–positive muscle fibers than in COX-neg-
ative fibers. Her other tissues are homoplasmic for wild-
type mtDNA, and her three children have been spared
the disease, suggesting that her germ-line mitochondria
are also free of the mutation.
Smith-Lemli-Opitz Syndrome Mutations, by Wassif et
al. (p. 55)
Smith-Lemli-Opitz syndrome (SLOS) is an inborn error
of cholesterol biosynthesis in which the final step of this
metabolic pathway, the reduction of 7-dehydrocholes-
terol, is deficient. Although this biochemical defect
emerged several years ago, the genetic basis of this dis-
ease has been uncertain. Now, Wassif et al. report the
cDNA sequence of the human sterol D-7 reductase
(DHCR7), which they identified by homology to known
plant and fungal enzymes. They show that fibroblasts
from SLOS individuals and from controls express
DHCR7 mRNA and that, as with other gene products
that act in this metabolic pathway, mutant and wild-
type DHCR7 mRNAs are down-regulated when cellular
cholesterol is sufficient for growth. Wassif et al. find four
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mutations that affect coding sequences of the reductase
gene from three unrelated affected people. That the wild-
type cDNA complements their biochemical defect seems
to indicate that the metabolic defect is a direct effect of
these mutations.
MMR-Gene Mutations in MTS, by Kruse et al.
(p. 63)
Muir-Torre syndrome (MTS) and hereditary nonpoly-
posis colorectal cancer (HNPCC) have been considered
distinct conditions, because MTS, by definition, presents
with tumors of the sebaceous gland. Still, there is con-
siderable phenotypic overlap between the two disorders,
including microsatellite repeat-length instability in tu-
mors and a high incidence of colorectal and endometrial
cancers; Kruse and coworkers now indicate that MTS
and HNPCC may be considered allelic conditions. Un-
derlying HNPCC are mutations in any of four DNA
mismatch-repair genes, and Kruse et al. find two of them,
hMSH2 and hMLH1, mutated in 9 of 13 families with
sebaceous and colorectal cancers. One of these lesions,
a nonsense mutation in hMSH2, had been identified pre-
viously in a family with HNPCC, raising the question
of whether any genetic differences exist between affected
families that exhibit sebaceous tumors and those that
do not.
PLP-Gene Duplications in PMD, by Woodward et al.
(p. 207)
Overexpression of the X-linked proteolipid protein gene
(PLP) occurs in Pelizeaus-Merzbacher disease (PMD)
and in several animal models of this neurological dis-
order. Two transcripts from PLP encode major com-
ponents of the myelin sheath, and mutations in this gene
can lead to defects in oligodendrocyte maturation and
to spasticity and death in infancy. Although PLP point
mutations have been reported to cause PMD, most dis-
ease alleles appear to be duplications that leave the gene
intact. Woodward and coworkers have characterized
four such events by interphase-FISH analysis. They show
that, in all cases, the duplication was transmitted to af-
fected boys by their unaffected mothers; this X-linked
recessive transmission has been reported before, but it
appears to be at odds with the etiology of the disease.
In other respects, as the authors note, PMD seems strik-
ingly similar to another hereditary neuropathy, Charcot-
Marie-Tooth type 1A, that can arise from duplications
in a myelin protein gene. Woodward et al. find that the
size of the duplication is different in each family, al-
though its distal end appears to be common, suggesting
that these distinct but related aneusomies have occurred
independently in the different families.
Mapping of Complex Traits with SNPs, by Zhao et al.
(p. 225)
Single-nucleotide polymorphisms (SNPs) promise to be
well suited to DNA chip-based genomic screening once
a suitably dense SNP map is available. The first chip
designed for this application is expected to allow 2,000
biallelic loci to be scored in a single manipulation. An-
ticipating the introduction of this technology, Zhao et
al. have simulated and attempted to analyze genotype
data that might arise from a moderately complex genetic
trait, one conferred independently by two linked genes.
They examine several statistical parameters that could
be calculated, and they find that both linkage and link-
age-disequilibrium analyses are successful in mapping
the causal loci, although the former is prone to false
positives. The most robust such analysis, the authors
suggest, may involve a combination of the two param-
eters. However, they note that this combined estimator
might be optimal in part because of the specific family
structures, allele frequencies, and other factors that they
assumed when simulating their data.
Mapping Genes in Admixed Populations, by
McKeigue (p. 241)
McKeigue has previously argued that recently admixed
populations represent an important resource for the
mapping of disease loci, because of the strong disequi-
librium that is expected between disease genes and
linked, parental population-specific marker alleles. His
earlier analysis exploited the transmission-disequilib-
rium test, which depends on parental heterozygosity at
marker loci. Because this condition is easily met in pop-
ulations very soon after admixture, the second genera-
tion (equivalent, in a laboratory setting, to the F2 gen-
eration in a cross between inbred strains) is most
appropriate for this kind of analysis. However, statistical
significance drops quickly in later generations and in
populations where the number of admixed generations
varies. Here, McKeigue suggests an alternative method:
conditioning the genotype analysis of an affected indi-
vidual on the contribution, to that individual’s parents,
of characteristic founding population-specific markers.
This method appears to be robust even when the precise
history of intermarriage in a family is unknown.
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